Interstitial deletions of the chromosome 9p21 segment encoding the p16/CDKN2A tumor suppressor gene (i.e., 9p21 deletions) are frequently observed in a variety of human cancers. A majority of these deletions in lymphoid leukemia have been indicated to be mediated by illegitimate V(D)J recombination. In the present study, to elucidate the molecular processes of 9p21 deletions in nonlymphocytic malignancies, breakpoints for these deletions were analysed in 21 lung cancer cell lines and 32 nonlymphocytic cancer cell lines of nine other histological types. In all, 32 breakpoints in 21 lung cancer cell lines and 56 breakpoints in 32 nonlung cancer cell lines were mapped in a 450-kb segment encompassing the CDKN2A locus with a 10-kb resolution. The largest number of breakpoints (i.e., seven breakpoints in lung cancer and 12 breakpoints in nonlung cancers) was mapped in a 10-kb region containing the CDKN2A gene. More precise mapping of these seven and 12 breakpoints revealed that none of these breakpoints were located within 50-bp intervals to each other in this 10 kb region. Cloning and sequencing of breakpoints in 18 representative cell lines (six lung and 12 nonlung cancers) further revealed that there were no significant homologies among breakpoints in these 18 cell lines. In 11 (61%) cell lines, 1-5-bp nucleotides were overlapped at breakpoint junctions. These results indicate that DNA double-strand breaks triggering 9p21 deletions do not occur at specific DNA sequences, although they preferentially occur in or near the CDKN2A locus. It was also indicated that two broken DNA ends are rejoined by nonhomologous end-joining repair, preferentially utilizing microhomologies of DNA ends, in the occurrence of 9p21 deletions. Oncogene (2003) 22, 3792-3798. doi:10.1038/sj.onc.1206589
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Structural analyses of breakpoints for interstitial deletions of the 9p21 segment (i.e., 9p21 deletions) have been performed in lymphoid leukemia to predict the molecular processes of these deletions during lymphoid leukemogenesis. Cayuela et al. (1997) mapped breakpoints in T-acute lymphoblastic leukemias and found three sites of breakpoint clustering in the CDKN2A and CDKN2B loci. We recently found that a majority of breakpoints in lymphoid leukemias of both T and B lineages were clustered at five sites in the 250-kb segment encompassing the CDKN2A locus (Kitagawa et al., 2002) . All the breakpoint cluster sites defined were o20 bp in size and contained sequences similar to heptamer-recombination signal sequences (RSSs), which are subjected to DNA double-strand breaks (DSBs) by the RAG complex in the V(D)J recombination at the immunoglobulin and T-cell receptor loci. We also found that RSS-like sequences at breakpoint cluster sites have V(D)J recombination potentials 150-38 000-fold less than that of the consensus RSS (Kitagawa et al., 2002) . Thus, it was indicated that 9p21 deletions in lymphoid leukemia are predominantly mediated by illegitimate V(D)J recombination between two ectopic RSS sites in the 9p21 segment. However, since V(D)J recombination activities are exclusively expressed in cells of lymphoid lineages (Lewis, 1994) , such a mechanism would be only applicable to lymphoid malignancies.
To our knowledge, there is only one report focusing on the structure of breakpoints for 9p21 deletions in nonlymphocytic malignancies (Pomykala et al., 1994) . Pomykala et al. characterized breakpoints for the interstitial deletions removing the interferon gene cluster, which are located approximately 400 kb distal to the CDKN2A locus, in two cases of glioma. Nonhomologous sequences were connected at the junctions in these cases; however, cloned breakpoints were not precisely mapped due to a lack of information of the human genome sequence. Our analysis of human genome databases today indicated that both the distal (telomeric-side) and proximal (centromeric-side) breakpoints in one case were located within the interferon gene cluster, suggesting that the deletion characterized did not lead to CDKN2A, CDKN2B and/or ARF inactivation. The location of the proximal breakpoint in the remaining case was not assigned to a single site, since the sequence of the proximal breakpoint matched to that of multiple LINE elements dispersed in the human genome. Therefore, it remains unclear whether these two cases were representatives for 9p21 deletions. Thus, the information on the breakpoints is still insufficient to deduce molecular processes of 9p21 deletions in nonlymphocytic malignancies.
However, the finding that nonhomologous DNAs are joined at breakpoint junctions in gliomas was interesting, since similar structures were also found at breakpoint junctions for interstitial deletions at several other chromosomal loci, 2q33, 13q14, 3p21.3 and 22q12, in cancers of the lungs, breasts, bone and retinas (Canning and Dryja, 1989; Kohno et al., 1996; Sekido et al., 1998 , Nishioka et al., 2000 . On the other hand, breakpoints for deletions in the FHIT locus, a common fragile site in chromosome 3p14, in 10 cell lines derived from nonhematological malignancies were predominantly mapped in LINE1 sequences, suggesting that LINE1 sequences are hot spots for DSBs (Inoue et al., 1997; Mimori et al., 1999) . At two breakpoint junctions, which were characterized in detail, two copies of LINE1 elements of 90% homology with each other in approximately 1500 bp were connected. Therefore, it was proposed that homologous recombination between LINE1 sequences results in FHIT deletions. Based on these results, we can hypothesize molecular processes of interstitial deletions in nonlymphocytic malignancies as follows. DSBs occur at specific DNA sequences. Illegitimate rejoining of DSBs is undertaken both by nonhomologous end joining (NHEJ) and homologous recombinational repair (HRR), which utilizes homologous DNAs such as repetitive sequences. In fact, the latter hypothesis is supported by recent findings that NHEJ and HRR are major repair pathways for DSB (Hoeijmakers, 2001) , and that chromosomal interstitial deletions in cultured mammalian cells are caused by illegitimate rejoining of DSBs both by NHEJ and HRR (Jasin, 2000; Tremblay et al., 2000) .
In this study, to understand the molecular process of 9p21 deletions in nonlymphocytic malignancies, breakpoints for such deletions were analysed in 31 lung cancer cell lines and 39 nonlymphocytic cancer cell lines of nine other histological types. All these cell lines have been shown to have homozygous 9p21 deletions (Kamb et al., 1994; Nobori et al., 1994; Tanaka et al., 1997; Hamada et al., 1998 Hamada et al., , 2000 Kohno, unpublished data) (Table 1) . Lung cancers were analysed because they show frequent 9p21 deletions (Hamada et al., 1998 (Hamada et al., , 2000 Park et al., 2002) . In addition, it has been suggested that chromosome deletions were largely triggered by exogenous factors such as tobacco carcinogens (Wistuba et al., 1997; Sanchez-Cespedes et al., 2001) . Other cell lines were analysed because they were also derived from cancer types often showing 9p21 deletions (Kamb et al., 1994; Nobori et al., 1994; Tanaka et al., 1997) .
The regions of homozygous 9p21 deletions in 31 lung cancer cell lines were first examined to map their 62 breakpoints (i.e., 31 distal and 31 proximal breakpoints). Deletions were examined using eight STS markers consisting of six markers derived from exons of the CDKN2A, CDKN2B and ARF genes and two other STS markers, STS-D and STS-P, which are located 226 kb distal to and 215 kb proximal to the ARF exon 1b locus, respectively ( Figure 1a) . As expected, all the cell lines showed deletions at one or more of the CDKN2A, CDKN2B and ARF loci. Ten (32%) cell lines showed deletions of both the STS-D and STS-P loci, indicating that the whole 441-kb region is deleted in these cell lines. Thus, they were not further analysed in this study. The remaining 21 (68%) cell lines retained one or both of the STS-D and STS-P loci (Table 1, Figure 1a ). In 11 of the 21 cell lines, both the STS-D and STS-P loci were retained, suggesting that interstitial deletions occurred in the 441-kb region and both the distal and proximal breakpoints were present in this region (cell lines 1-11 in Figure 1a ). In the remaining 10 cell lines, either the STS-D or STS-P locus was retained; therefore, either the distal or proximal breakpoint was suggested to be present in the 441-kb region (cell lines 12-21 in Figure 1a ). In total, 32 breakpoints in 21 cell lines were indicated to be present in the 441-kb region between the two loci. The 450-kb region, which includes the 441-kb region between the STS-D and STS-P loci, was divided into 45 regions of 10 kb in size as shown in Figure 1a , and the 32 breakpoints located between the two loci were mapped to some of the 10-kb regions by using a number of STS markers. In all, 31 breakpoints were mapped into some of the 45 regions, while the remaining one breakpoint was mapped into the region of 20 kb in size, since it was mapped in a contiguous repetitive sequence ranging across the 420-430-and 430-440-kb regions (cell line 6, Figure 1a ). The 200-210-kb region encoding all the CDKN2A exons contained seven (22%) breakpoints, while other regions contained two or less breakpoints. The seven breakpoints in the 200-210-kb region were more precisely mapped using STS markers placed at 50-bp intervals, and were shown to be located with intervals of 450 bp to each other. We also mapped the remaining 25 breakpoints, which were mapped outside the 200-210-kb region, more precisely. These breakpoints were also located with intervals of 450 bp to each other. Thus, it was indicated that DSBs triggering 9p21 deletions do not occur at specific sites but at diverse sites, although they preferentially occur in or near the CDKN2A locus. Six lung cancer cell lines were subjected to the cloning and sequencing of breakpoints. Four cell lines had either or both of their breakpoints in the 200-210-kb region (cell lines in orange, Figure 1a) , while the other two cell lines had both breakpoints outside the 200-210-kb region (cell lines in green, Figure 1a ). Genomic fragments containing breakpoint junctions were cloned by inverse PCR or genomic PCR using sets of primers recognizing the regions flanking the breakpoints. Deletions in five of the six cell lines were simple interstitial ones; thus, the structures of 10 breakpoints at five junctions were determined. The remaining one cell line, A549, had a discontinuous deletion with the insertion of an inverted 327-bp fragment located between the MTAP and CDKN2A loci (cell line 2, Figure 1a) . Therefore, the structures of four breakpoints at two junctions were defined in this cell line. In total, the structures of 14 breakpoints at seven junctions were defined in six lung cancer cell lines (Figure 2a, b) . All of the 14 breakpoints were assigned in the 450-kb region (Figure 1a) . No significant homology was found between the 60-bp sequences evenly spanning the distal and proximal breakpoints in any of the cell lines in a Blast2 program analysis (http://www.ncbi.nlm.nih.gov/blast/). Two breakpoints (14%) were mapped in repetitive sequences (Figure 1a) . However, repetitive sequences were not over-represented at breakpoints, because the 450-kb region contained approximately 227 kb (50%) of interspersed repetitive sequences. In our previous study of 9p21 deletions in lymphoid leukemia (Kitagawa et al., 2002) , the CAC trinucleotide, the indispensable trinucleotide in RSSs subjected to DSBs in V(D)J recombination, was found to be over-represented in the 23-bp sequences flanking breakpoints. In this study, overrepresentation of the CAC trinucleotide was also examined at 14 breakpoints cloned in lung cancer. However, CAC was not over-represented at breakpoints in lung cancer according to the criteria used in the analysis of lymphoid leukemia (Kitagawa et al., 2002) (data not shown). Therefore, it was unlikely that the RAG complex generates DSBs triggering 9p21 deletions in lung cancer. Thus, it was indicated that DSBs for 9p21 deletions in lung cancer do not occur at specific DNA sequences.
Next, the regions of homozygous 9p21 deletions in 39 cancer cell lines of nine histological types other than lung cancer were examined to map their 78 breakpoints (i.e., 39 distal and 39 proximal breakpoints), as in the analysis of lung cancers. In 24 cell lines, both the distal and proximal breakpoints were suggested to be present in the 441-kb region (cell lines 1-24 in Figure 1b) , while, in eight other cell lines, either the distal or proximal breakpoint was suggested to be present in this region (cell lines 25-32 in Figure 1b) . In total, 56 breakpoints in 32 cell lines were indicated to be present in this 441-kb region. These 56 breakpoints were further mapped with a 10-kb resolution (Figure 1b) . The 200-210-kb region contained the largest number of breakpoints (12 breakpoints, 21%), while the 220-230-kb region contained nine (16%) breakpoints. The other regions contained five or less breakpoints. The 12 and nine breakpoints in the 200-210-and 220-230-kb regions, respectively, were more precisely mapped using STS markers placed at 50-bp intervals. All these Interspersed repetitive sequences spanning the cloned breakpoints are described next to each breakpoint. Cell lines subjected to breakpoint cloning are in orange, blue or green (see text). PCR-based homozygous deletion mapping was performed as described previously (Hamada et al., 1998) . The primer pairs used for the analysis of the CDKN2A, CDKN2B and ARF loci were reported previously (Park et al., 2002) . The primer pairs for the STS-D and STS-P loci are 5 0 -GAACGAATCCACCAGGATGC-3 0 /5 0 -TGGCCTGCTTGCTTTACATC-3 0 and 5 0 -CGCAAGTTCTCTCCTGGAAG-3 0 /5 0 -CCTGCAAGTCAGTTGCAATC-3 0 , respectively. The genome sequence for the 450-kb region was obtained by processing sequences deposited in Genbank, AB060808, AL359922, AL449423, AL354709 and AL157937, by Sequencher program Version 3.1.1 (Gene Codes, Ann Arbor, MI, USA). Repetitive sequences were assigned by using the REPEATMASKER program (http://ftp.genome.washington.edu/cgibin/RepeatMasker). The locations of breakpoints mapped outside the 450-kb region were defined by the analyses of the NCBI and Celera genome databases Molecular processes for 9p21 deletions in human cancers S Sasaki et al breakpoints were located with intervals of 450 bp to each other. Since the 200-210-kb region contained the largest number of breakpoints both in lung and nonlung cancers, we further searched for breakpoint clustering in the 200-210-kb region by analysing the 12 breakpoints in nonlung cancer together with the seven breakpoints in lung cancer. These 19 breakpoints were located with intervals of 450 bp to each other.
In all, 12 nonlung cancer cell lines were subjected to the cloning and sequencing of breakpoints. Six cell lines had breakpoints in the 200-210-kb region (cell lines in Breakpoints were cloned by the inverse-PCR method (Ochman et al., 1988) or genomic PCR using primers that recognize sequences flanking distal and proximal breakpoints, respectively. In inverse PCR, DNA (1 mg) was digested with 10 units of restriction enzyme with four to six base pair recognition sites. For circularization, the digested DNA was ligated in a 100 ml reaction with six units of T4 DNA ligase (Promega, Madison, WI, USA) and a ligation buffer at 161C. Circular products were amplified by PCR using primers that recognize sequences located on the known part of the rearranged fragment. PCR products were sequenced using the ABI 310 DNA Sequence System (PE Biosystems, Tokyo, Japan) directly or after they were subcloned into the pGEM-T easy vector by using a pGEM-T easy vector system I kit (Promega). Sequences of the DNA fragments obtained by the inverse-PCR method were confirmed by the direct sequencing of the PCR products, which were obtained by genomic PCR using the primers that recognize sequences flanking distal and proximal breakpoints, respectively orange, Figure 1b) , and three cell lines had breakpoints in the 220-230-kb region (cell lines in blue, Figure 1b) . The remaining three cell lines had both breakpoints outside the 200-210-and 220-230-kb regions (cell lines in green, Figure 1b) . Deletions in 11 of the 12 cell lines, excluding that in MG63, were simple interstitial ones. Of the 22 breakpoints in the 11 cell lines, 21 were assigned into the 450-kb region, while the proximal breakpoint in U178 was mapped outside the 450-kb region and approximately 4 Mb proximal to the STS-P locus (cell line 29, Figure 1b) . In the remaining cell line, MG63, a DNA fragment containing a breakpoint junction was cloned by inverse PCR undertaken from the distal breakpoint. However, the fragment joined with the distal breakpoint was found to be derived from the region approximately 5 Mb distal to the 441-kb region analysed in this study. Therefore, we could not define the proximal end of the deletion in MG63 (cell line 26, Figure 1b ). No significant homology was found between the 60-bp sequences evenly spanning the distal and proximal breakpoints in any of the 12 cell lines. Specific repetitive sequences were not over-represented at these breakpoints ( Figure 1b ). In addition, the CAC trinucleotide was not over-represented at the breakpoints (data not shown). Thus, it was indicated that DSBs triggering 9p21 deletions in nonlymphocytic malignancies other than lung cancer do not occur at specific sequences, either, although they preferentially occur in or near the CDKN2A locus.
In total, 19 breakpoint junctions were cloned from 18 cell lines (six lung and 12 nonlung cancers). Notably, 1-5-bp nucleotides overlapped at 12 (63%) junctions (Figure 2a ). In particular, two or more nucleotides overlapped in 11 (92%) of these cases. This could occur by chance at frequencies of p1/16 if two or more nucleotide sequences were randomly aligned. Thus, the result indicates that DSBs triggering 9p21 deletions in nonlymphocytic malignancies were preferentially rejoined by NHEJ utilizing microhomologies of broken DNA ends (Lieber, 1999; Hoeijmakers, 2001) . At seven other junctions (37%), DNAs were directly joined (Figure 2b ) or joined with insertion of several nucleotides (Figure 2c) . The joining at these seven junctions was also likely to be undertaken by NHEJ, since NHEJ is also undertaken without utilizing a terminal microhomology and sometimes accompanied with insertion of extra nucleotides (Roth and Wilson, 1986; Smith et al., 2001) . This result was unexpected. In fact, 14 (37%) of the 38 breakpoints, which were cloned and sequenced in this study, were located in the repetitive sequences ( Figure 1) ; therefore, we thought it possible that some DSBs were rejoined by HRR utilizing the same types of repetitive sequences in the 9p21 segment. To further investigate this issue, we mapped breakpoints of 11 lung cancer cell lines, in which both the distal and proximal breakpoints were mapped in the 450-kb region (cell lines 1-11, Figure 1a ), more precisely (data not shown). However, in no cell lines were the distal and proximal breakpoints mapped within the same type of repetitive elements located in the same direction. Therefore, no evidence of HRR through repetitive sequences was obtained. Instead, the results further supported that rejoining of broken DNAs leading to 9p21 deletions was exclusively undertaken by NHEJ in nonlymphocytic malignancies.
The results of this study have made us predict molecular processes for 9p21 deletions in nonlymphocytic malignancies as follows. DNA double-strand breaks triggering 9p21 deletions do not occur at specific sequences, although they preferentially occur in or near the CDKN2A locus. Two broken DNA ends are rejoined by NHEJ, preferentially utilizing microhomologies, in the occurrence of 9p21 deletions. The present results on 9p21 deletions and previous results on FHIT (3p14) deletions indicate that molecular pathways underlying deletions are different among chromosomal regions. To elucidate genomic sequences susceptible to DSBs underlying 9p21 deletions, we examined nucleotide homologies among 60-bp sequences evenly spanning the 38 breakpoints, which were cloned and sequenced in this study. However, significant homologies were not observed among these breakpoints. We next searched for mono-, di-and trinucleotides over-represented among these 38 sequences of 60 bp in size; however, statistically significant over-representation was not observed for any of mono-, di-and trinucleotides (data not shown). Thus, at present, nucleotide sequences susceptible to DSBs in the CDKN2A locus remain unclear. Interestingly, recent studies have indicated that the packaging structure of chromatin affects the susceptibility to several DNAdamaging agents (Smerdon and Conconi, 1999) . Thus, it is also possible that the open chromatin structure associated with the CDKN2A gene expression rather than nucleotide sequences might be responsible for susceptibility to DSBs. Up to the present, breakpoints for deletions at chromosomal regions other than the FHIT and CDKN2A loci have been characterized in only a few cases. Thus, analyses of breakpoints at diverse chromosomal regions in a variety of and a larger number of human cancers would be necessary for our further understanding the mechanisms of chromosomal deletions.
